Immunotherapy has long-term benefit for patients with advanced Merkel cell carcinoma
June 5, 2018
Susan Keown, of Fred Hutch News, released an article on June 4, 2018 highlighting the significant impact immunotherapy has had on MCC patients. Investigators, including Dr. Paul Nghiem, presented new, long-term data from clinical trials that showed how immunotherapy drugs have helped a significant subset of patients with this cancer survive much longer than would otherwise be possible. To read more, view the article here.
The authoritative source on Merkel cell carcinoma.
Last updated:
November 27, 2024
About the Disease
- What is a Merkel cell?
- What is Merkel cell carcinoma?
- Symptoms & appearance of Merkel cell carcinoma
- Causes of Merkel cell carcinoma
Testing & Diagnosis
Created in partnership with:
Seattle Multidisciplinary MCC Team, University of Washington MCC Research, and Fred Hutchinson Cancer Center.